CounterFlow Hemostatic Gauze Provides Military Medics Confidence and Demonstrates Effective Hemorrhage Control in a Live Tissue Simulation
Military Medicine · 2025
DOI: 10.1093/milmed/usaf057 ↗Kurz gefasst
Fachartikel in der Zeitschrift Military Medicine, 2025. Verfasst von Nabil Ali-Mohamad und 9 weiteren Autor:innen. Beteiligte Einrichtung: Trauma and Acute Care Surgery, Faculty of Medicine, St. Michael's Hospital, University of Toronto, Toronto, ON M5B 1W8, Canada. Hauptthemen laut MEDLINE: Hemorrhage, Hemostatics, Bandages, Hemostatic Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: by Canadian Forces Health Services, the CF Surgeon General's Health Research Program, Defence Research and Development Canada, the U.S. Department of Defense.
Abstract (Originalsprache)
Introduction
Trauma-induced hemorrhage is the leading cause of preventable death on the battlefield, with anatomical junctional wounds accounting for ∼19% of deaths. This highlights the need for effective hemorrhage control interventions. Consequently, CounterFlow-Gauze was developed to deliver thrombin, tranexamic acid (TXA), and calcium through a self-propelling acid–base reaction, eliminating the need for manual compression. This study evaluates the usability and efficacy of CounterFlow-Gauze to the Committee on Tactical Combat Casualty Care standard of care, Combat Gauze. Materials and Methods Ten Canadian Armed Forces medics tested the usability CounterFlow-Gauze and Combat Gauze in a swine junctional hemorrhage model. A 4-mm vascular punch was used to induce femoral injury, followed by a 15-second free bleed. Medics packed the wound and applied 3-minute compression. Medics were blinded to the gauze treatment and completed surveys to evaluate the gauzes. Animals were observed for 3 hours or until death, and blood loss was measured. Blood samples were also collected to measure TXA levels and establish baseline and treated values for blood gas, hematological, and coagulation parameters.
Results
Medics reported enhanced usability and greater efficacy of CounterFlow-Gauze (4.3 ± 0.9/5) compared to Combat Gauze (3.0 ± 1.2 /5; P < .05) in attenuating bleeding. CounterFlow-Gauze achieved high survivability (10/10 animals) and low blood loss (10.21 ± 1.83 g/kg) compared to Combat-Gauze (9/10 animals, 12.72 ± 3.03 g/kg; P > .05), while delivering systemic therapeutic levels of TXA by 30 minutes (10.92 ± 0.17 µg/mL). Changes in mean arterial pressure and heart rate were less pronounced with CounterFlow-Gauze compared to Combat Gauze (P > .05), while no differences were observed between baseline and treated values for any of the other measured parameters.
Conclusions
The self-propelling hemostatic agents of CounterFlow-Gauze may compensate for suboptimal packing by novice users or in high-stress situations. These findings support the adoption of CounterFlow-Gauze, providing all soldiers access to superior but restricted hemostatic agents in a safe and easy-to-use gauze on the battlefield.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Trauma and Acute Care Surgery, Faculty of Medicine, St. Michael's Hospital, University of Toronto, Toronto, ON M5B 1W8, Canada.
- Michael Smith Laboratories, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
- Defence Research and Development Canada, Toronto Research Centre, North York, ON M3K 2C9, Canada.
- Canadian Forces Health Services, Ottawa, ON K1A 0K2, Canada.
- School of Biomedical Engineering, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
- Defence Research and Development Canada, Suffield Research Centre, Medicine Hat, AB T1A 8K6, Canada.
ORCID-Profile: Nabil Ali-Mohamad, Kanwal Singh, Massimo F Cau, Henry Peng, Christian J Kastrup, Andrew Beckett
Förderung
- by Canadian Forces Health Services, the CF Surgeon General's Health Research Program
- Defence Research and Development Canada
- the U.S. Department of Defense
- by Canadian Forces Health Services, the CF Surgeon General’s Health Research Program
Zitieren
APA
Ali-Mohamad, N., Singh, K., Cau, M. F., Tenn, C., Bince, D., Kamide, C., Peng, H., Semple, H., Kastrup, C. J., & Beckett, A. (2025). CounterFlow Hemostatic Gauze Provides Military Medics Confidence and Demonstrates Effective Hemorrhage Control in a Live Tissue Simulation. Military Medicine. https://doi.org/10.1093/milmed/usaf057
Vancouver
Ali-Mohamad N, Singh K, Cau MF, Tenn C, Bince D, Kamide C, et al. CounterFlow Hemostatic Gauze Provides Military Medics Confidence and Demonstrates Effective Hemorrhage Control in a Live Tissue Simulation. Military Medicine. 2025. doi:10.1093/milmed/usaf057
BibTeX
@article{AliMohamad2025,
author = {Ali-Mohamad, Nabil and Singh, Kanwal and Cau, Massimo F and Tenn, Catherine and Bince, Danielle and Kamide, Colin and Peng, Henry and Semple, Hugh and Kastrup, Christian J and Beckett, Andrew},
title = {CounterFlow Hemostatic Gauze Provides Military Medics Confidence and Demonstrates Effective Hemorrhage Control in a Live Tissue Simulation},
journal = {Military Medicine},
year = {2025},
doi = {10.1093/milmed/usaf057}
}
EUVIMED